SM-324405 (9e, intratracheal administration) effectively inhibits allergen-induced airway inflammation without inducing cytokines systemically[1].
SM-324405 is metabolized to the corresponding acid in human plasma with t1/2 of 2.6 min[1][2].
IC 50
TLR7: 50 nM (EC50); human TLR7: 7.3 (pEC50); Rat TLR7: 6.6 (pEC50)